FINANCE ROUNDUP: An IPO in a tough stock market, two VC deals
This article was originally published in Scrip
Executive Summary
Benitec Pharma's painfully small initial public offering during the week of Aug. 17 to 21 was emblematic of recent pain felt within the broader US stock market, but private investors kept to their commitments to fund early-stage and pre-commercial biotechnology venture capital rounds.